We describe a recipient of combined kidney and hematopoietic-cell transplants from an HLA-matched donor. A post-transplantation conditioning regimen of total lymphoid irradiation and antithymocyte globulin allowed engraftment of the donor's hematopoietic cells. The patient had persistent mixed chimerism, and the function of the kidney allograft has been normal for more than 28 months since discontinuation of all immunosuppressive drugs. Adverse events requiring hospitalization were limited to a 2-day episode of fever with neutropenia. The patient has had neither rejection episodes nor clinical manifestations of graft-versus-host disease.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMoa074191 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Maternal immune activation does not affect maternal microchimeric cells.
Biol Open
December 2024
Research Center for Integrative Evolutionary Science, SOKENDAI 240-0193 Shonan Village, Hayama, Kanagawa, Japan.
We are naturally chimeras. Apart from our own cells originating from the fertilized egg, placental mammals receive small numbers of maternal cells called maternal microchimerism (MMc) that persist throughout one's whole life. Not only are varying frequencies of MMc cells reported in seemingly contradicting phenomena, including immune tolerance and possible contribution to autoimmune-like disease, but frequencies are observable even among healthy littermates showing varying MMc frequencies and cell type repertoire.
View Article and Find Full Text PDFClinical relevance of feto-maternal microchimerism in (hematopoietic stem cell) transplantation.
Semin Immunopathol
December 2024
Division of Pediatric Stem Cell Transplantation and Immunology, Clinic of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, 20246, Hamburg, Germany.
Toleration of a semi-allogeneic fetus in the mother's uterus as well as tolerance after allogeneic hematopoietic stem cell transplantation (HSCT) appear to share some immunologic concepts. The existence of microchimeric cells, and the original idea of a bidirectional cell trafficking between mother and child during pregnancy have been known for decades. Today, origins and mechanisms of persistence of microchimeric cells are intensively being elucidated.
View Article and Find Full Text PDFCellular trafficking and fate mapping of cells within the nervous system after in utero hematopoietic cell transplantation.
Commun Biol
December 2024
Washington University in St. Louis School of Medicine, Department of Surgery, Division of Pediatric Surgery, St. Louis, MO, USA.
Article Synopsis
- - In utero hematopoietic cell transplantation (IUHCT) takes advantage of the fetus's immune tolerance to successfully introduce donor cells without prior conditioning or immunosuppression, aiming for long-lasting cell integration.
- - A study injected adult bone marrow cells into fetal mice at gestational ages 12-17 days, finding the highest concentration of donor cells in the brain when injected between GA 13-14, with significant persistence of these cells in the hindbrain.
- - This research is groundbreaking as it details how donor cells migrate into the nervous system during fetal development, laying the groundwork for using IUHCT to potentially treat neurogenetic disorders.
Pregnancy induced displacement of preexisting microchimeric cells in the absence of maternal B and T cells.
Front Immunol
November 2024
Division of Infectious Diseases, Center for Inflammation and Tolerance, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.
Bidirectional exchange of cells between mother and fetus occurs during pregnancy, and persistence of these genetically foreign cells establishes long-term microchimerism in both individuals after parturition. Since women can have multiple pregnancies, and all mothers were once daughters themselves, the microchimeric milieu in each woman could theoretically contain cells from a variety of origins, including from their own mothers as well as their babies from each pregnancy. Interestingly and in sharp contrast to this prediction, we recently showed preexisting populations of microchimeric cells are lost following pregnancy and associated with seeding of new fetal microchimeric cells.
View Article and Find Full Text PDFEffect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease.
Transplant Cell Ther
November 2024
Division of Hematology & HSCT, Department of Oncology, King Abdulaziz Medical City, Ministry of National Guards-Health Affairs, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; Saudi Scientific Society of Blood and Marrow Transplantation, Jeddah, Saudi Arabia. Electronic address:
Article Synopsis
- * ABO blood group mismatch and alloimmunization can significantly affect the success of HCT in SCD patients, leading to complications like hemolysis and graft failure.
- * This study analyzed data from 194 SCD patients over 14 years old who underwent HCT and focused on the effects of RBC incompatibility and alloimmunization on transplant outcomes and overall survival.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!